牛霞,万龙,郑鑫,车尔玺,孙长山,王思玲
NIU Xia1,WAN Long1,ZHENG Xin2,CHE Er-xi1,SUN Chang-shan1,WANG Si-ling1(1.School of Pharmacy

• 1:沈阳药科大学药学院
• 2:沈阳药科大学制药工程学院

摘要(Abstract)：

目的为了提高难溶性药物西洛他唑的溶出度,制备西洛他唑/介孔碳固体分散体。方法以表面活性剂F127为胶束模板,以酚醛树脂的乙醇溶液为碳源制备介孔碳,选用西洛他唑作为模型药,采用吸附平衡挥干法和溶液吸附法载药制得西洛他唑固体分散体,采用扫描电镜、氮气吸附-脱附和热分析手段表征介孔碳及西洛他唑/介孔碳固体分散体的性质。结果制得的介孔碳孔径均一,其孔径主要集中在6.3 nm,载体的比表面积为1 255.4 m2.g-1,孔容为1.441 cm3.g-1,载体的载药质量可高达33.1%,溶出数据表明西洛他唑/介孔碳固体分散体的溶出速率与累积溶出度与药物西洛他唑相比均有了显著提高。结论介孔碳有望成为能提高难溶性药物溶出度的优良载体。
Objective To improve the water-insoluble drug cilostazol(CLT) dissolution via the preparation of the cilostazol-mesoporous carbon solid dispersion.Methods The mesoporous carbon was obtained using Pluronic block co-polymer F127 as template and ethanol solution of resols as the carbon souse by the soft template.The morphology,specific surface area and pore size distribution were studied by the scanning electron microscopy and the nitrogen adsorption/desorption.The cilostazol/mesoporous carbon solid dispersion was prepared by evaporating solvent and filtering solvent,respectively.Though differential scanning calorimetry and the dissolution experiment,the basic properties of cilostazol solid dispersion were researched.Results The mesoporous carbon was showed on SEM images.The pore size was focused on 6.7 nm.The specific surface area was reaching up to 1 255.4 m2 · g-1 and the volume of 1.441 cm3 · g-1.The dissolution of cilostazol was dramatically improved compared with the pure drug.Conclusions Mesoporous carbon is expected to become the prospect of water-insoluble drug carrier.

关键词(KeyWords)： 介孔碳;固体分散体;西洛他唑;溶出性质
mesoporous carbon;solid dispersion;cilostazol;dissolution property

Abstract:

Keywords:

基金项目(Foundation): 国家重大基础研究计划项目(2009CB930300)

作者(Author): 牛霞,万龙,郑鑫,车尔玺,孙长山,王思玲
NIU Xia1,WAN Long1,ZHENG Xin2,CHE Er-xi1,SUN Chang-shan1,WANG Si-ling1(1.School of Pharmacy

DOI: 10.14066/j.cnki.cn21-1349/r.2012.08.006

参考文献(References)：

• [1]HU Yan-chen,ZHI Zhuang-zhi,Zhao Qin-fu,et al.3Dcubic mesoporous silica microsphere as a carrier forpoorly soluble drug carvedilol[J].Microporous and Me-soporous Materials,2012,147(1):94-101.
• [2]ZHANG Yan-zhuo,ZHI Zhuang-zhi,JIANG Tong-ying,et al.Spherical mesoporous silica nanoparticles forloading and release of the poorly water-soluble drugtelmisartan[J].Journal of Controlled Release,2010,145(3):257-263.
• [3]WU Chao,WANG Jing,HU Yan-chen,et al.Develop-ment of a novel starch-derived porous silica monolithfor enhancing the dissolution rate of poorly water solu-ble drug[J].Materials Science and Engineering,2012,32(2):201-206.
• [4]ZHAO Qin-fu,WANG Tian-yi,WANG Jing,et al.Fab-rication of mesoporous hydroxycarbonate apatite for oraldelivery of poorly water-soluble drug carvedilol[J].Journal of Non-Crystalline Solids,2012,358(2):229-235.
• [5]ZHAO Qin-fu,WANG Tian-yi,WANG Jing,et al.Tem-plate-directed hydrothermal synthesis of hydroxyapatiteas a drug delivery system for the poorly water-solubledrug carvedilol[J].Applied Surface Science,2011,257(23):10126-10133.
• [6]JIANG Hai-tao,WANG Tian-yi,WANG Li-hong,et al.Development of an amorphous mesoporous tio2 nano-sphere as a novel carrier for poorly water soluble drugs:effect of different crystal forms of tio2 carriers ondrugloading and release behaviors microporous and meso-porous matericals[J].Microporous and MesoporousMaterials,2012,153:124-130.
• [7]ZHAO Peng,WANG Li-hong,SUN Chang-shan et al.Uniform mesoporous carbon as a carrier for poorly watersoluble drug and its cytotoxicitty study[J].EuropeanJournal of Pharmaceutics and Bippharmaceutics,2012,80(3):535-543.
• [8]LI Yu-ting,WANG Tian-yi,WANG Jing,et al.Func-tional and unmodified MWNTs for delivery of the water-insoluble drug carvedilol-a drug-loading mechanism[J].Applied Surface Science,2011,257(13):5663-5670.
• [9]ZHAO Peng,JIANG Hai-tao,JIANG Tong-ying,et al.Inclusion of celecoxib into fibrous ordered mesoporouscarbon for enhanced oral bioavailability and reducedgastric irritancy[J].European Journal of Pharmaceuti-cal Sciences,2012,45(5):639-647.
• [10]WANG Tian-yi,ZOU Mei-juan,JIANG Hai-tao,et al.Synthesis of a novel kind of carbon nanoparticle withlarge mesopores and macropores and its application asan oral vaccine adjuvant[J].European Journal ofPharmaceutical Sciences,2011,44(5):653-659.
• [11]MIAO Xiao-qing,SUN Chang-chan,JIANG Tong-ying,et al.Investigation of nanosized crystalline form to im-prove the oral bioavailability of poorly water solublecilostazol[J].Journal of Pharmacy&PharmaceuticalSciences,2011,14(2):196-214.
• [12]JINNO J,KAMADA N,MIYAKE M,et al.In vitro-invivo correlation for wet-milled tablet of poorly water-soluble cilostazol[J].Journal of Controlled Release,2008,130(1):13029-13037.
• [13]PATEL S G,RAJPUT S N.Enhancement of oral bio-availability of cilostazol by forming its inclusion com-plexes[J].AAPS PharmSciTech,2009,10(2):660-669.
• [14]JINNO J,KAMADA N,MIYALE M,et al.Effect ofparticle size reduction on dissolution and oral absorp-tion of a poorly water-soluble drug,cilostazol,in beagledogs[J].Journal of Controlled Release,2006,111(1-2):56-64.
• [15]ZHAI Yun-pu,DOU Yu-qian,LIU Xiao-xia,et al.Soft-template synthesis of ordered mesoporous carbon/nano-particle nickel composites with a high surface area[J].CARBON,2011,49(2):545-555.